ArticleBriefings in bioinformatics2026
De Bruijn graphs for pangenomics: in-depth performance benchmarking of de Bruijn graph-based tools for read mapping.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
De Bruijn graphs are widely used in pangenome representation due to their numerous advantages and extensions, such as colored and compacted variants that enhance the representation of genetic variation. Although de Bruijn graphs are becoming increasingly adopted, their performance and energy impact have not been clearly studied. Such an overlooked understanding can lead to suboptimal designs for de Bruijn graph-based tools in addressing the computational challenges posed by pangenome data. To identify workflow bottlenecks and assess the efficiency of hardware utilization, we present an in-depth performance analysis of state-of-the-art de Bruijn graph-based read mapping tools on pangenomic datasets, focusing on scalability of execution time, hardware resource utilization, and energy consumption. We observe that the tools primarily prioritize data parallelism for processing read datasets, disregarding the increasing complexity of the pangenome graph, which hinders scalability. As the pangenome graph grows in size and complexity, cache miss rates also increase, leading to poor overall performance. By extensively analyzing sources of suboptimal performance, we pave the way for optimizing the existing and future tools to fully realize their potential in advancing pangenome research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.